Trial intelligence / Profile preview

CoviVac in Children Aged 12-17

NCT05715918Phase 3Unknown

Start
Apr 2022
Primary completion
Dec 2023
Countries
1
01

Overview

A Phase 3 trial of COVI-VAC in coronavirus disease 2019 (COVID-19). Status: unknown.

02

Drugs

COVI-VAC
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT05715918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05715918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call